HGT-2310

Showing 1 posts of 1 posts found.

Shire image

Shire lifted by rare disease approvals

January 26, 2015
Sales and Marketing HGT-2310, Hunter syndrome, SHP609, Shire, fast track, idursulfase-IT, rare disease

Shire’s investigational drug for a rare neurological disease has been accepted into the FDA’s fast-track approval process. The drug, SHP609, …

The Gateway to Local Adoption Series

Latest content